semaglutide infographic | Nudge Fit Rise of Semaglutide: Novo Nordisk,

The current scientific consensus, based on over 15 years of clinical use and extensive research, is that there is no evidence of a causal association between GLP-1 receptor agonists and pancreatic cancer

Metabolaid and HOWARU Shape are also shown to support the growth of Akkermansia muciniphila *, a beneficial gut microbe associated with microbiome balance

Injecting too deeply can speed up absorption, which may increase the risk of hypoglycemia

Medical Interventions : For patients with recurrent UTIs, prophylactic antibiotics may be considered

Temporary treatment pauses or dose adjustments may be necessary

Patients undergoing active cancer treatment must obtain explicit oncologist approval before supplementing